Open AccessTransarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
Author(s) -
Jun Guo,
Shao-Xing Liu,
Song Gao,
Fuxin Kou,
Xin Zhang,
Di Wu,
Xiaoting Li,
Hui Chen,
Xiaodong Wang,
Peng Liu,
Pengjun Zhang,
Haifeng Xu,
Guang Cao,
Linzhong Zhu,
Renjie Yang,
Xu Zhu
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i27.3975
Subject(s) - hepatocellular carcinoma , medicine , chemotherapy , gastroenterology , oncology
Transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) have shown promising local benefits for advanced hepatocellular carcinoma (HCC). S-1, a composite preparation of a 5-fluorouracil prodrug, has proven to be a convenient oral chemotherapeutic agent with definite efficacy against advanced HCC.